US$ 20.86
semaglutide bubble guts Managing GI Discomfort on GLP-1s: Causes & Relief Strategies Frontiers | Effects of semaglutide
Description
While all three medications mimic GLP-1 hormone to control hunger, Wegovy is specifically approved for weight loss with a 2.4mg weekly dose, while Ozempic targets diabetes management at 2mg

However, these cross-trial comparisons must be interpreted with considerable caution : the trials differed in population characteristics, duration, dosing schedules, and primary endpoints
Side effects were consistent with those seen for obesity therapies, including gastrointestinal symptoms (nausea, diarrhea and constipation) and an elevated rate of dysesthesia (abnormal skin sensations), reported in about 20.9% of patients on the highest dose

Glucose, glycation, and RAGE: implications for amplification of cellular dysfunction in diabetic nephropathy

References Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS (2023) Global burden of heart failure: a comprehensive and updated review of epidemiology